These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 15324353)
1. Long-term cyclosporin A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts. Yamaguchi M; Naruishi K; Yamada-Naruishi H; Omori K; Nishimura F; Takashiba S J Periodontal Res; 2004 Oct; 39(5):320-6. PubMed ID: 15324353 [TBL] [Abstract][Full Text] [Related]
2. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. Yamada H; Nishimura F; Naruishi K; Chou HH; Takashiba S; Albright GM; Nares S; Iacopino AM; Murayama Y J Periodontol; 2000 Jun; 71(6):955-60. PubMed ID: 10914799 [TBL] [Abstract][Full Text] [Related]
3. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. Hyland PL; Traynor PS; Myrillas TT; Marley JJ; Linden GJ; Winter P; Leadbetter N; Cawston TE; Irwin CR J Periodontol; 2003 Apr; 74(4):437-45. PubMed ID: 12747447 [TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation. Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636 [TBL] [Abstract][Full Text] [Related]
5. The up-regulation of type I plasminogen activator inhibitor in human gingival fibroblasts stimulated with cyclosporin A. Lin HJ; Tsai CH; Huang FM; Chang YC J Periodontal Res; 2007 Feb; 42(1):39-44. PubMed ID: 17214638 [TBL] [Abstract][Full Text] [Related]
6. IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts. Yamaguchi T; Naruishi K; Arai H; Nishimura F; Takashiba S J Cell Physiol; 2008 Nov; 217(2):423-32. PubMed ID: 18543249 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin B, D, and L regulation in cyclosporin A-mediated gingival hyperplasia of a patient with sarcoidosis. Murai O; Naruishi K; Ogihara S; Suwa N; Kanazawa S; Yaegashi T; Takeda Y; Kunimatsu K Clin Lab; 2011; 57(7-8):535-41. PubMed ID: 21888018 [TBL] [Abstract][Full Text] [Related]
8. Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice. Nishimura F; Naruishi H; Naruishi K; Yamada T; Sasaki J; Peters C; Uchiyama Y; Murayama Y Am J Pathol; 2002 Dec; 161(6):2047-52. PubMed ID: 12466121 [TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva. Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333 [TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporin A on human gingival fibroblast collagen turnover in relation to the development of gingival overgrowth: an in vitro study. Gagliano N; Moscheni C; Dellavia C; Torri C; Stabellini G; Ferrario VF; Gioia M Biomed Pharmacother; 2004 May; 58(4):231-8. PubMed ID: 15183848 [TBL] [Abstract][Full Text] [Related]
11. cAMP-response element binding protein (CREB) regulates cyclosporine-A-mediated down-regulation of cathepsin B and L synthesis. Omori K; Naruishi K; Yamaguchi T; Li SA; Yamaguchi-Morimoto M; Matsuura K; Arai H; Takei K; Takashiba S Cell Tissue Res; 2007 Oct; 330(1):75-82. PubMed ID: 17724614 [TBL] [Abstract][Full Text] [Related]
12. Dose-dependent stimulation/inhibition effects of cyclosporin A on lysosomal cathepsin activities in cultured proximal tubule cells. Ling H; Vamvakas S; Schaefer L; Schramm L; Paczek L; Daemmrich J; Schaefer RM; Heidland A Res Exp Med (Berl); 1995; 195(6):355-64. PubMed ID: 8904025 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. Kataoka M; Shimizu Y; Kunikiyo K; Asahara Y; Yamashita K; Ninomiya M; Morisaki I; Ohsaki Y; Kido JI; Nagata T J Cell Physiol; 2000 Mar; 182(3):351-8. PubMed ID: 10653601 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients. Tüter G; Serdar MA; Yalim M; Gürhan IS; Baloş K J Periodontol; 2002 Nov; 73(11):1273-8. PubMed ID: 12479630 [TBL] [Abstract][Full Text] [Related]
16. Expression of proteolytic cathepsins B, D, and L in periodontal gingival fibroblasts and tissues. Trabandt A; Müller-Ladner U; Kriegsmann J; Gay RE; Gay S Lab Invest; 1995 Aug; 73(2):205-12. PubMed ID: 7637320 [TBL] [Abstract][Full Text] [Related]
17. Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines. Sukkar TZ; Thomason JM; Cawston TE; Lakey R; Jones D; Catterall J; Seymour RA J Periodontal Res; 2007 Dec; 42(6):580-8. PubMed ID: 17956473 [TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporine and phenytoin on biomarker expressions in gingival fibroblasts of children and adults: an in vitro study. Vahabi S; Salman BN; Rezazadeh F; Namdari M J Basic Clin Physiol Pharmacol; 2014 May; 25(2):167-73. PubMed ID: 23907422 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. Bolzani G; Della Coletta R; Martelli Júnior H; Martelli Júnior H; Graner E J Periodontal Res; 2000 Feb; 35(1):51-8. PubMed ID: 10791709 [TBL] [Abstract][Full Text] [Related]
20. Regulation of type I plasminogen activator inhibitor in human gingival fibroblasts with cyclosporine A. Ho YC; Lin HJ; Tsai CH; Chang YC Oral Dis; 2010 May; 16(4):396-401. PubMed ID: 20233320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]